A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants
Clinical trial NCT06868082 · COMPLETED
Trial details
- NCT number
- NCT06868082
- Sponsor
- Uniquity One (UNI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2026-02-02
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.